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Background: A major constraint for the effective control and management of helminth parasites is the lack of
rapid, high-throughput, routine diagnostic tests to assess the health status of individual animals and herds and
to identify the parasite species responsible for these helminthoses. The capability of a multiplex platform for the
simultaneous detection of three pasture associated parasite species was evaluated and compared to existing ELISAs.
Methods: The recombinant antigens 14.2 kDa ES protein for Cooperia oncophora, major sperm protein for
Dictyocaulus viviparus and Cathepsin L1 for Fasciola hepatica were recombinantly expressed either in Escherichia
coli or Pichia pastoris. Antigens were covalently coupled onto magnetic beads. Optimal concentrations for coupling
were determined following the examination of serum samples collected from experimentally mono-infected
animals, before and after their infection with the target species. Absence of cross-reactivity was further determined
with sera from calves mono-infected with Haemonchus contortus, Ostertagia ostertagi and Trichostrongylus colubriformis.
Examination of negative serum samples was characterised by low median fluorescence intensity (MFI).
Results: Establishment of the optimal serum dilution of 1:200 was achieved for all three bead sets. Receiver Operating
Characteristic analyses were performed to obtain cut-off MFI values for each parasite separately. Sensitivity and
specificity at the chosen cut-off values were close to, or 100 % for all bead sets. Examination of serum samples
collected on different days post infection from different animals showed a high reproducibility of the assays. Serum
samples were additionally examined with two already established ELISAs, an in-house ELISA using the recombinant
MSP as an antigen and a DRG ELISA using Cathepsin L1 for liver fluke. The results between the assays were
compared and kappa tests revealed an overall good agreement.
Conclusions: A versatile bead-based assay using fluorescence detection (xMAP® technology) was developed to
simultaneously detect antibodies against C. oncophora, D. viviparus and F. hepatica in cattle serum samples. This
platform provides rapid, high-throughput results and is highly sensitive and specific in comparison to existing
serological as well as coproscopical diagnostic techniques.
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Nematode and trematode infections play an important
role for animal welfare and are of great concern for the
economy of the global ruminant livestock industry today
[1]. Constantly increasing financial costs for anthelminthic
prophylaxis and treatment due to the spread of anthel-
mintic resistant parasite populations, as well as the often
overlooked subclinical effects of the helminth infections
on animal productivity [2, 3] have led to the need of
developing new and sustainable strategies concerning the
effective control of helminthoses. An important step to-
wards this end is the development of new, efficient and
high-throughput diagnostic techniques. Despite the devel-
opment of more sensitive coproscopical methods [4], they
often target individual animals and are not suitable for
high-throughput diagnosis. Serological methods estab-
lished so far appear to lack specificity, in particular when
non-recombinant antigens are used, and multiple tests
have to be performed to detect mixed species infections.
Amongst the helminths responsible for pasture-borne
parasitoses the liver fluke, lungworm as well as gastro-
intestinal (GI) nematodes are the most important for
cattle in temperate climate regions. Cooperia oncophora,
a parasite of the small intestine of cattle occurs worldwide
with high prevalence rates [5, 6]. It is usually associated
with Ostertagia ostertagi, parasitising the abomasum, and
both contribute to the complex of parasitic gastroenteritis
(PGE) [1]. While O. ostertagi is known to be more
pathogenic, C. oncophora is generally considered as the
dose-limiting species [7], particularly for the macrocyclic
lactone (ML) anthelmintics. Infections with these GI nem-
atodes as well as with the bovine lungworm Dictyocaulus
viviparus cause considerable decrease in weight gain in
calves during the first grazing [8] season, can be respon-
sible for significant reduction in milk yield [9, 10] and im-
pair animal welfare [11]. The economic importance of
such parasitic diseases has been repeatedly demonstrated
[12], especially where intensive grazing management is
practiced, and cost-benefit evaluations have indicated that
financial losses due to the presence of GI nematodes can
be high [2, 13]. Monitoring data provided by the Dutch
Animal Health Service for D. viviparus indicate that the
incidences of parasitic bronchitis tended to increase in the
Netherlands [14]. In the same study, economic losses of
approximately 160 € per cow were calculated. The liver
fluke Fasciola hepatica affects large and small ruminants.
In cattle, fasciolosis can appear as a chronic and subclin-
ical form and is worldwide considered as one of the most
important parasitic diseases causing substantial economic
losses, which are estimated to be 2000 million $ (USA)
per year in agriculture [15, 16]. Additionally, this parasite
has zoonotic potential and environmental contamination
through infected animals can be important for human
health [17].Diagnosis of these parasites is commonly based on
coproscopical detection methods such as sedimentation
(liver fluke), flotation (GI nematodes) or baermannisa-
tion of larvae (lungworm). Since eggs excreted by most
GI nematodes are morphologically indistinguishable, spe-
cies identification can only be achieved following faecal
culturing or using molecular techniques [18–20]. The
generally high handling costs as well as the necessity to
sample several animals led to the increased use of
serological methods which can be used for herd health
monitoring. Serological diagnosis of F. hepatica has been
described in the literature using excretory/secretory (ES)
products [21–23], a “f2” antigen (Fasciolosis Verification
Test, IDEXX, Hoofddorp, the Netherlands) and a recom-
binant Cathepsin L1 antigen [22]. The same applies for D.
viviparus where the detection of antibodies in serum or
milk using ELISAs with either crude ES antigen [24–26]
or recombinantly expressed major sperm protein (MSP)
[27–29] has been described. For the detection of C. onco-
phora, ELISA using crude antigen [30], or a recombinantly
expressed 14.2 kDa ES protein [31] were reported.
All these ELISA only target a single species and in order
to cover the spectrum of pasture-borne helminthoses,
multiple assays have to be conducted. Recent technical ad-
vances offer the advantage of multiplex assays, resulting in
higher throughput, increased flexibility, reduced sample
volume and lower costs [32–34]. A popular multiplex
platform is the bead-based Luminex® xMAP® technology
(Luminex Corp., Austin, TX). The basis are different poly-
styrene beads which are labelled with distinct ratios of two
fluorescent dyes (red and near-infrared), leading to more
than 100 sets of distinguishable beads, which are also re-
ferred to as microspheres in the literature. With each set,
different analytes can be measured in parallel in a single
assay [35, 36]. Various ligands can be covalently conju-
gated to the surface of these beads. If antigens are used as
ligands, assays equivalent to ELISAs can be developed. In-
teractions of the target analytes with antibodies is detected
using biotinylated secondary antibodies and streptavidin,
labelled with the reporter fluorochrome phycoerythrin
(SA-PE). Fluorescence detection in the Luminex xMAP
liquid suspension array system is achieved by two-laser
flow cytometry [37]. This technology is relatively widely
used in the field of human medical diagnosis [38] but
only few reports have been published in the field of
veterinary diagnosis, particularly regarding serological
assays [39–41].
The aim of this study was to develop a new, versatile
diagnostic assay for the simultaneous detection of spe-
cific antibodies against F. hepatica, D. viviparus and C.
oncophora in cattle serum samples. The performance of
the Luminex® platform was evaluated through compari-
son with already established ELISAs using the same or
different antigens.
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Serum samples and antigens
The standardisation of the assay was achieved by using
control sera obtained from parasite naïve animals before
(negative control) and after experimental mono-infection
with the target parasites D. viviparus, (100 larvae over 5
consecutive days) C. oncophora (30,000–40,000 larvae)
and F. hepatica (500 metacercariae). For testing specificity
as well as cross reactivity, sera from animals mono-
infected with other important GI nematodes, Haemonchus
contortus, Trichostrongylus colubriformis and O. ostertagi
were used. All animal experiments were conducted in
strict accordance with the respective local legislation and
the European guideline for animal experiments (2010/
63/EU). They were approved by a) the Landesamt für
Gesundheit und Soziales, Berlin, Germany under the
reference number L 0088/10, b) the Ethical Commission
of the Faculty of Veterinary Medicine, Ghent University,
Belgium under the reference number EC2009/086 and
c) the Swedish Animal Ethics Committee under the
permission C4/2.
Additionally serum samples collected in Denmark
(n = 39), Switzerland (n = 76) and Poland (n = 367) were
used. In Denmark and Switzerland, samples were taken
from grazing young cattle on randomly selected farms.
The sampling in Poland took place on farms previously
identified for a cross-sectional survey using a two-stage
sampling approach [42]. On a subset of those farms, 10–
15 first season grazing cattle were randomly sampled.
The antigen used for the detection of F. hepatica was
a recombinant 37 kDa Cathepsin L1-like protein [43] pro-
vided by ILDANA BIOTECH, UCD, Dublin. It is an active
site [Cys26Gly] mutant expressed in the yeast Pichia pas-
toris. For the detection of antibodies against D. viviparus
the recombinant 43 kDa MSP expressed as a glutathione-
S-transferase (GST) fusion protein in Escherichia coli
BL21 (DE3) cells as previously described by Gozdzik et al.
[27] was used.
Production of recombinant C. oncophora ES 14.2 antigen
The protein used for the detection of antibodies against
C. oncophora was a 14.2 kDa ES protein described previ-
ously by Poot et al. [31]. A codon optimised (E. coli) ver-
sion of the open reading frame (ORF) was synthesised
in vitro (SynthesisGene®; China). The ORF was amplified
using the forward primer (5′-CAC CAA TGA ATA TAC
CGA TGC ACT GGC AAA ATG TAC-3′) and reverse
primer (5′-TTA TTC CCA ATA CAG ACA CAG AAC
TTT CAG TT-3′). PCR products were cloned into the
pET151 TOPO expression vector (Life Technologies). A
Rosetta gami® (Novagene) E. coli clone containing the
pET151/CoES14.2 was cultured at 37 °C until OD600nm
reached 0.6. Synthesis of the ES14.2-V5-6 × His protein
was induced with 0.5 mM isopropylthio-galactoside(IPTG) at 37 °C for 4 h. The recombinant ES14.2-V5-
6 × His protein was purified from inclusion bodies using
Protino® Ni-IDA columns (Macherey-Nagel, Germany)
according to the manufacturer’s protocol. An additional
wash step using a 50 mM concentration of imidazole
and 2 % Tween20 was conducted before elution with
250 mM imidazole. Purity of the eluted protein was ana-
lysed on 12 % SDS–PAGE, stained with GelCode™ col-
loidal coomassie stain (ThermoFisher). Western blotting
using an anti-V5 antibody (Life Technologies) was car-
ried out to confirm that the target protein was obtained.
Antigen coupling to fluorescent beads
In order to remove sodium azide or imidazole, D. viviparus
and C. oncophora recombinant antigens were purified by
gel filtration using Micro Bio-Spin 6 chromatography col-
umns (Bio-Rad, Germany) according to the manufacturer’s
protocol. Concentrations of all antigens were determined
using the CB-X™ Assay (G-Biosciences, USA).
D. viviparus, C. oncophora and F. hepatica antigens
were conjugated on the surface of carboxylated magnetic
beads (Bio-Plex Pro™ Magnetic COOH Beads – 1.25 ×
107 beads/ml, Bio-Rad) using the fluorescence regions
026, 062 and 065, respectively. Coupling reactions were
performed using the Amine Coupling Kit® (Bio-Rad),
following a two-step carbodiimide reaction protocol pro-
vided by the manufacturer. The stock suspension of
uncoupled beads was vortexed at high speed for 30 s
followed by sonication for 15 s in order to disperse bead
aggregates. A 100 μl aliquot of monodisperse COOH
beads (1.25 × 106) was transferred to one Bio-Plex coup-
ling reaction tube and was placed into the magnetic sep-
arator for 30 to 60 s before removal of the supernatant.
The beads were washed once in 100 μl bead wash buffer,
followed by re-suspension in 80 μl bead activation buf-
fer. Then 10 μl of 50 mg/ml N-Hydroxysulfosuccinimide
sodium salt (S-NHS) (Sigma-Aldrich, Germany) and 10 μl
of 50 mg/ml N-(3-Dimethylaminopropyl)-N’-ethylcarbo-
diimide hydrochloride (EDAC) (Sigma-Aldrich), which
were prepared in bead activation buffer immediately prior
to their use, were added. The reaction tube was mixed
gently, covered with aluminium foil and then gently agi-
tated on a shaker for 20 min at room temperature (RT).
PBS (pH 7.4, 150 μl) was added twice, always followed by
vigorous vortexing. The recombinant protein was added
and total volume was brought to 500 μl with PBS (final
antigen concentration 5–12 μg/500 μl). Incubation was
performed on a shaker at high speed (600–700 rpm) at
RT for 2 h. In order to achieve higher coupling yields,
some alterations of the initial protocol were made. It
was observed that beads incubated at medium speed
(500 rpm) as recommended had a tendency to precipi-
tate at the bottom of the coupling reaction tube. There-
fore, speed was slightly increased and the coupling
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to prevent precipitation.
Initially, different concentrations were used for each of
the three antigens and were separately tested in order to
determine the optimum antigen concentration. The
amounts of the conjugated protein were the following
for each bead-set: for C. oncophora 7 μg, 5 μg, 3.5 μg,
2.5 μg, 1.75 μg, 1.25 μg, 0.9 μg and 0.45 μg, for D. vivi-
parus 5 μg, 2.5 μg, 1.25 μg, 0.66 μg and 0.45 μg, and for
F. hepatica 5 μg, 2.5 μg and 1.25 μg. The coupled beads
were placed into a magnetic separator for 1 min and
after removal of the supernatant they were washed with
500 μl of PBS. The coupled beads were then re-suspended
in 250 μl of blocking buffer and gently agitated at RT in
the darkness for 30 min. Finally, the beads were washed
with 500 μl of storage buffer, re-suspended in 150 μl stor-
age buffer and stored at 4 °C in the dark. Beads were
stored on the recommended conditions and always used
within 4 months after coupling since decreased perform-
ance was observed thereafter.
Luminex multiplex assay
The assays were conducted in 96-well polystyrene,
round-bottom microplates (Greiner Bio-One). The three
bead-sets were initially tested in singleplex assays includ-
ing negative controls as well as the respective positive
control sera. These were used in a two-fold eight serial
dilution series in PBS/Tween20 (0.05 %, pH 7.4) in order
to identify the optimal sample dilution. Cross-reactivity
was assessed by running the assay with sera from calves
infected with non-target species. Then, the three bead-
sets were combined in a bead-mix and a multiplex assay
was performed.
Prior to each examination, beads were re-suspended
by vortexing and sonication for approximately 20 s three
times to avoid high numbers of aggregated beads. A
50 μl aliquot of the working beadmixture (concentration
100 beads/μl) was transferred into the wells, followed by
the addition of 50 μl of diluted sera. The plate was incu-
bated on a plate shaker (800 rpm) in the dark at RT for
60 min. The plate was then placed into the magnetic
separator and left for separation for 60 s. The super-
natant was carefully removed from each well by manual
inversion. Beads were washed 5 times by adding 100 μl
PBS/Tween20 into each well to ensure absence of any
undesirable or non-specifically bound antibodies. The
plate was then removed from the magnetic separator and
100 μl of a biotinylated secondary antibody (goat anti-
bovine IgG, Dianova, Germany) diluted 1:1000 in PBS/
Tween20 were added to each well. Incubation was again
conducted in darkness and at RT on a plate shaker
(800 rpm) for 30 min before beads were washed as de-
scribed above. Finally, 100 μl of streptavidin-phycoerythrin
(SA-PE, Millipore) at 2 μg/ml, diluted in assay buffer, wereadded to each well. The plate was placed on the shaker,
covered with aluminium foil and again incubated at RT on
a plate shaker (800 rpm) for 30 min. The supernatant was
carefully removed after magnetic separation of the beads
by manual inversion and washing was performed as
previously described. Assay buffer (100 μl) was added into
each well and the plate was placed onto a plate shaker for
approximately 15 s in order to achieve gentle agitation of
the beads.
The beads were analysed using the Bio-Plex 200
instrument following the manufacturer’s instructions. A
minimum of 100 events (beads) per well was read for
every bead-set. All samples were analysed in duplicates
in each run. To investigate reproducibility of the assays,
several (between three and six) runs were performed
using the sera from the same animals.ELISA used for comparison
Result obtained using the Luminex® assay were com-
pared to existing ELISAs. D. viviparus antibodies were
detected using either an in-house ELISA for lungworm
based on the recombinant MSP antigen as described in
von Holtum et al. [29] or using the modification of this
ELISA as described by Gozdzik et al. [27]. Antibodies
against F. hepatica were detected using either an in-
house ELISA for liver fluke based on crude ES antigen
following the method described by Salimi-Bejestani et al.
[23] or the commercially available DRG liver fluke ELI-
SAs (using recombinant Cathepsin L1). For the detec-
tion of C. oncophora antibodies no commercial ELISA is
currently available and therefore no comparison was
conducted.Statistical analysis
GraphPad Prism® software 5.04 was used for the statis-
tical analyses. Five parameter logistic regression curves
were calculated in order to determine the optimal serum
dilution for each bead set separately. For differentiation,
positive and negative samples as well as sera from ani-
mals infected with non-target species were compared
using box plots. Negative and positive cut-off MFI values
for each parasite specific assay were obtained using
receiver operating characteristics (ROC) analysis to de-
termine at the same time sensitivity and specificity. The
respective values are automatically provided with the
95 % confidence intervals in the software used.
For comparison with existing ELISA (F. hepatica and
D. viviparus) two subsets of 39 and 370 serum samples,
respectively, were examined and Kappa tests were
performed.
Percentages with confidence intervals and differences be-
tween countries were calculated using a Mid-P exact test in
OpenEpi (http://www.openepi.com/Menu/OE_Menu.htm).
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Optimal amount of protein for coupling
The optimal amount of antigen identified for the target
species were 0.45 μg for both, D. viviparus and C. onco-
phora, and 2.5 μg for F. hepatica. These were deter-
mined based on the amount of conjugated protein that
would provide a reliable and reproducible MFI signal,
which enabled a clear differentiation between positive
and negative serum control samples.
Optimisation of secondary antibody dilutions and SA-PE
concentration
Using the optimal amount of antigen, four different
secondary antibody dilutions (1:500, 1:1000, 1:2000 and
1:5000) and four SA-PE concentrations (0.5 μg/ml, 1 μg/
ml, 2 μg/ml and 4 μg/ml) were tested. Optimal results
were obtained for a 1:1000 dilution for the biotinylated
secondary antibody and a concentration of 2 μg/ml for
SA-PE.
Optimal serum dilution
Determination of the optimal serum dilution was based
on the examination of negative and positive control sera
in a two-fold dilution series ranging from 1:100 to
1:12,800 for the separate coupled beadsets. The logistic
regression curves of the MFI values for all three target
species enabled a clear differentiation between the target
species and negative control as well as non-target spe-
cies (Fig. 1) with relatively low background MFI values.
Multiplex assays were also performed using an 82-fold
dilution series and results were comparable to those ob-
tained in the singleplex assays (Fig. 2).
For all assays R2 values were close to 1. To achieve an
optimal discrimination between positive and negative sera
for all three bead sets a dilution of 1:200 was chosen.
Assessment of cross-reactivity and cut-off determination
All bead sets were examined using positive and negative
control sera as well as sera from non-target species
infections. Since no obvious differences were observed
between singleplex and multiplex assays, results were
combined and are shown in Fig. 3. Box plots indicated
clear differentiation between positive and negative con-
trol serum samples for all three target species. Regarding
cross-reactivity antigens used for the detection of C.
oncophora and F. hepatica could clearly distinguish be-
tween infections with target and non-target species (H.
contortus, T. colubriformis, O. ostertagi, D. viviparus and
F. hepatica or C. oncophora, respectively). This was
different for the recombinant MSP antigen, where cross-
reactivity was more pronounced for sera from C. onco-
phora and F. hepatica infected animals; particularly for a
few C. oncophora positive sera differences to the lowest
observed MFI value for D. viviparus were only minimal.Determination of the cut-off MFI values, sensitivity and
specificity was achieved by ROC analysis separately for
each bead set. Since serum samples were derived from
experimentally infected animals and either clearly nega-
tive (parasite naïve prior to infection) or positive, two
cut-off values were defined, one discriminating negative
and one positive, leaving grey zone in between. For D.
viviparus the situation was slightly different with some
cross-reactivity present particularly for the C. oncophora
coupled beads, so that for this assay only one cut-off
value was determined. The cut-off values with sensitivity
and specificity including the 95 % confidence intervals
are presented in Table 1.
Assay reproducibility
Serum samples were obtained from different animals on
different days pre and post infection and tested multiple
times independently as well as in parallel on the same
plate in order to determine the reproducibility of the
assay. The MFI values obtained indicated reproducible
results, which are shown in Table 2. The results obtained
for the individual animals showed distinct immune re-
sponses, resulting in different levels of mean MFI values.
Although CV were relatively high for some individuals
when testing for antibodies against D. viviparus, all indi-
vidual values clearly identified the respective samples as
positive.
Comparison between multiplex assay and single ELISAs
and field validation
The validation of this multiplex assay was performed
by comparing the results obtained from the examin-
ation of individual serum samples with already existing
and established assays.
Initially, only positive and negative samples derived
from experimentally infected animals pre and post infec-
tion (F. hepatica and D. viviparus) were compared, using
an in-house ELISA for lungworm as described by von
Holtum et al. [29] as well as an in-house ELISA for liver
fluke based on crude ES antigen. The results obtained
were identical for both, negative as well as positive con-
trol sera.
To increase the number of samples tested, additionally
serum samples collected during a field trial in Poland
were used for comparison. Thirty-nine of these samples
were analysed using the commercially available DRG
liver fluke ELISAs. For the detection of lungworm no
commercial ELISA is currently available. Serum samples
were analysed in parallel in Sweden using an in-house
ELISA [27]. In the latter, all samples were negative for
D. viviparus antibodies while one sample was detected
positive in the Luminex assay. Due to the fact that al-
most all samples were negative, no kappa statistic could
be calculated. The comparison with the DRG liver fluke
Fig. 1 Results for singleplex assays using serum dilutions of cattle
infected with Dictyocaulus, Fasciola and Cooperia. Five parameter
logistic regression curves were calculated based on median
fluorescence intensity (MFI) values. a Cooperia oncophora coupled
beads using sera positive for C. oncophora (green), Dictyocaulus
viviparus (black), Fasciola hepatica (red) and negative control sera
(blue). b D. viviparus coupled beads and c F. hepatica coupled beads
using the same sera. Dilutions are presented as 0.005 ≙ 1:200
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maximum achievable). For this calculation the negative
cut-off values for both assays were used. A larger subset
of 363 samples were analysed using the commercially
available SVANOVIR®F.hepatica-AbELISA (protocol iden-
tical to the in-house liver fluke ELISA as mentioned
above) in the laboratory in Ghent. The comparison re-
sulted in a kappa value of 0.460 (74.4 % of 0.67 maximal
achievable). While 67 samples were positive only in the
Luminex, there were also 21 samples which appeared
positive in the ELISA but clearly negative in the Luminex
assay.
Finally the newly developed triplex Luminex assay was
used to analyse field serum samples collected in Denmark
(n = 39), Switzerland (n = 76) and Poland (n = 367). The
results obtained show no or low rates of lungworm infec-
tion in all three countries. C. oncophora appears in higher
rates in Poland (73.8 %) in comparison to Denmark
(28.2 %) and Switzerland (48.7 %). Additionally in Poland,
increased levels of liver fluke were detected. Significant is
the number of samples classified in the grey zone, whichFig. 2 Results for the triplex assay using serum dilutions of cattle
infected with Dictyocaulus, Fasciola and Cooperia. Five parameter
logistic regression curves were calculated based on median
fluorescence intensity (MFI) values. Beads are coupled with
recombinant antigen for the detection of Cooperia oncophora
(green), Dictyocaulus viviparus (black) and Fasciola hepatica (red).
Artificial mixtures of sera from animals infected with the target
species was used. Dilutions are presented as 0.005 ≙ 1:200
Fig. 3 Cross reactivity analysis using sera from target and non-target
species. Results are presented as box-plots showing the median
fluorescence intensity (MFI) values obtained from multiple testing
of sera from negative and mono-infected animals. Bead set were
coupled with recombinant antigen for the detection of Cooperia
oncophora (a), Dictyocaulus viviparus (b) and Fasciola hepatica (c).
Whiskers represent 5 % and 95 % percentage quantiles and the
mean is indicated by a +. Outliers are shown as individual dots
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lated percentages are presented in Table 3.
Discussion
Pasture-borne parasitoses are highly prevalent in all
grazing ruminants and have been recognised as import-
ant issues for animal welfare and productivity [2, 44].
This is particularly referring to the liver fluke, the lung-
worm and GI nematodes. Accelerated problems regarding
anthelminthic resistance, climate change, intensification of
farming and altered management practices have increased
the need of development of new techniques in order to ac-
curately diagnose and monitor these diseases.
In the current study, the successful development of a
triplex assay for the simultaneous detection of antibodies
against C. oncophora, D. viviparus and F. hepatica in
serum from cattle is reported. While widely used single-
plex assays using recombinant antigens were available
for the latter two, expression of a C. oncophora antigen
is described that was previously only once described for
use in an ELISA. The new triplex assay was established
using control sera from parasite naïve or controlled
experimentally infected animals. Cross reactivity was
assessed for all three antigens using the target parasites
and revealed reliable detection with high sensitivity and
specificity. Additionally, three non-target trichostrongy-
lid nematode species (H. contortus, O. ostertagi and T.
colubriformis) have been included in cross reactivity
testing. Inclusion of Nematodirus, Paramphistomum and
other important pasture-borne parasites would have
been desirable, however, infection doses or serum of ex-
perimentally mono-infected animals were presently not
available. Nevertheless, the evaluation of cross-reactivity
presented here includes more parasite species than eval-
uated for many already commercialised assays.
Standardisation of any serological assay requires the
use of defined negative and positive control sera col-
lected from parasite naïve animals before and after
specific mono-infection with the target parasites as well
as non-target species. However, particularly regarding
cross-reactivity, this information is often not accessible
for commercially available assays. Also for the large
number of developed and evaluated in-house ELISAs as-
sessment of cross reactivity has often not been per-
formed or at least not been reported. The specificity of
Table 1 Results of the Receiver Operating Characteristics analysis for negative (neg.) and positive (pos.) cut-off values. Median
fluorescence intensity (MFI), sensitivity and specificity with confidence intervals (CI) are shown
MFI Specificity 95 % CI Sensitivity 95 % CI
C. oncophora
Neg. cut-off 379 99.84 % 99.11–100 % 100 % 98.17–100 %
Pos. cut-off 997 100 % 99.41–100 % 99.50 % 97.25–99.99 %
D. viviparus
Cut-off 950.5 100 % 99.32–100 % 100 % 97.93–100 %
F. hepatica
Neg. cut-off 340.8 99.46 % 97.01–99.99 % 100 % 98.02–100 %
Pos. cut-off 2670 100 % 98.02–100 % 99.46 % 97.01–99.99 %
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testing the bead sets with sera obtained from animals
infected with other important species for livestock (H.
contortus, O. ostertagi and T. colubriformis). No cross-
reactivity was obtained for all non-target species and all
bead sets. For C. oncophora and F. hepatica also no
cross-reactivity was detected for the other target species.
For the detection of C. oncophora the 14.2 kDa recom-
binant antigen as reported by Poot et al. [31] was used.
These authors reported no cross reactivity when serum
samples from animals mono-infected with O. ostertagi
or D. viviparus were used in their ELISA. This mirrors
the result obtained in the current study, where no cross
reactions were observed for any of the parasite species
tested, leading to a sensitivity and specificity of 100 %.
For the detection of F. hepatica the recombinant
Cathepsin L1 antigen was used. No cross reactivity was
observed for any of the other species tested, also result-
ing a 100 % sensitivity and 100 % specificity. This is
different to what has been reported in the literatureTable 2 Results of technical reproducibility using serum from differe
Animal 1 Animal 2
C. oncophora
N 8 8
Mean MFI value 2236 3778
CV 3.29 % 2.11 %
D. viviparus
N 12 8
Mean MFI value 2332 3738
CV 4.47 % 5.32 %
F. hepatica
N 12 10
Mean MFI value 1583 1888
CV 9.39 % 9.64 %
N number of replicates
MFI median fluorescence intensity
CV coefficient of variationregarding the use of this antigen. Kuerpick and col-
leagues [22] observed two false positive results out of 13
animals infected with D. viviparus and one out of four
animals infected with C. oncophora (sensitivity between
90–100 %, specificity 88.6 %). Cornelissen et al. [45] ob-
tained similar findings with five out of 191 animals in-
fected with D. viviparus, one out of 31 animals infected
with C. oncophora and one out of 55 animals infected
with O. ostertagi (sensitivity 99.1 %, specificity 98.5 %).
The currently observed absence of cross reactivity might
not be confirmed in the Luminex® assay upon the use of
significantly higher number of animals infected with
non-target species. However, a similar level of cross re-
activity as described above in the ELISAs would still be
an improvement in comparison to systems using com-
plex antigens such as ES antigen with reported specific-
ities between 83–96 % [44].
The D. viviparus bead set was coupled with the re-
combinant MSP antigen. Although no or only minimal
cross reactivity have been reported by von Holtum et al.nt experimentally infected animals
Animal 3 Animal 4 Animal 5
8 8 8
3870 3124 2876
3.33 % 4.78 % 6.12 %
6 6 6
2595 1923 1472




Table 3 Percentage of serum samples positive for antibodies
against Cooperia oncophora, Dictyocaulus viviparus and Fasciola
hepatica. Results for the field samples are shown per country
and include 95 % confidence intervals (95 % CI)
Denmark (n = 39) Poland (n = 367) Switzerland
(n = 76)
C. oncophora 28.21%a 73.84%b 48.68%c
95 % CI 16.42–43.90 % 69.11–78.08 % 37.78–59.71 %
D. viviparus 0%ab 3.82%b 0%a
95 % CI 0–10.68 % 2.23–6.34 % 0–5.77 %
F. hepatica 64.10%ac 79.84%b 67.11%c
95 % CI 48.73–77.31 % 75.42–83.63 % 55.91–76.65 %
Percentages which do not share the same indices (a, b, c) are significantly
different in a Mid-P exact test (p < 0.05)
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et al. [27] (sensitivity 97.7 %, specificity 98.1 %) for ELI-
SAs using the same recombinant antigen, a few MFI
values obtained for sera from animals infected with C.
oncophora were very close to the lowest values of D.
viviparus infected animals. However, no overlaps of MFI
values occurred. In comparison to sera from negative
animals or animals infected with O. ostertagi or H.
contortus, MFI values obtained for sera from animals in-
fected with F. hepatica and C. oncophora were substan-
tially elevated. This background prevented the definition
of two cut-off values separating clearly negative and
clearly positive from the intermediate grey zone. The
absence of two cut-off values for D. viviparus might
complicate interpretation of field data in future epi-
demiological studies. In the field situation, some animals
will be in the prepatency period or have already cured
the infection but still have elevated antibody titres. MFI
values for such animals can be expected to fall in the
intermediate zone between negative and positive cut-off.
Without such an intermediate zone, it will become diffi-
cult to identify such animals. Regarding D. viviparus it is
also important to keep in mind that vaccination with at-
tenuated larvae is possible. A cross reactivity of serum
from vaccinated cattle is not expected since MSP is not
expressed in premature stages and adult parasites do
usually not develop. Additionally a sub-unit vaccine show-
ing partial protection has been described recently [46].
Here cross reactivity should also not occur since entirely
different recombinant antigens are used. However, experi-
mental evidence for this is not available yet.
Out of the currently available coproscopical, sero-
logical and molecular techniques for the diagnosis and
the identification of parasites only the first two are
routinely used. The sensitivity and specificity of the dif-
ferent techniques are extremely variable. Serological as-
says have the advantage of their implementation as herd
health monitoring tools. All currently available assays
are only capable of diagnosing antibodies against oneparasite and are often limited in their specificity due to
the use of complex crude or ES antigens. Despite the fact
that for all three parasite species of interest, C. oncophora,
D. viviparus and F. hepatica, ELISAs using recombinant
antigens have been described, only for the latter is a com-
mercial ELISA using recombinant antigen available. Mul-
tiplexing diagnostic systems are well established in human
medicine, but in veterinary medicine this technology has
so far not been extensively used. However, during recent
years several commercial or “in-house” bead-based multi-
plex assays have been developed, particularly in the field
of virology [39, 47, 48], where existing ELISAs were com-
pared with the new multiplexing assays revealing generally
better performance for the latter. Additionally, xMAP
technology has been used for the detection of inflamma-
tory markers, [49–52]. In the field of parasitology,
serological multiplex assays have only been reported for
the simultaneous detection of Trichinella spiralis and
Toxoplasma gondii in pigs [40, 41] and for the detection
of Plasmodium falciparum in humans [53]. The Luminex®
technology offers the advantage of reduced volume
needed for diagnosis [39]. When multi-plexing assays,
the costs per analyte are considerably lower in the
Luminex® assay than in a standard ELISA, whereas the
time needed for the examination of the samples is gener-
ally similar but reduced labour time per assay is achieved.
After the establishment of the Luminex assay, field
samples obtained from naturally infected grazing animals
during a trial in Poland have been used for comparison of
the new Luminex® assay with already established ELISAs.
In the case of multiplex bead-based immunoassays, com-
parison of the Luminex is frequently made with sero-
logical assays, such as ELISA. Correlation of these two
methods varies among literature [34, 54–59]. In the
current study, agreement between the assays was generally
good when the same (recombinant) antigen was used. In
case of the lungworm assay it was almost impossible to
calculate kappa values since only one animal out of the 39
samples tested appeared positive (only in the new assay).
The comparison of the DRG ELISA with Luminex was
complicated by the fact that this ELISA uses five different
categories and it was unclear, how to handle samples
negative or positive in the Luminex assay and “question-
able” or “low to moderate infection” in the other. Most of
the deviations in classification were due to the fact, that
the number of positive samples was higher in the Luminex
assay but there were also one sample classified as negative
in the Luminex but positive with the ELISA. Comparison
of the Luminex® data with the ELISA using the ES antigen
for F. hepatica detection had the advantage of a high
number of samples tested. This resulted in a better kappa
value than that obtained for the first comparison, however,
there was a high number of samples positive in only one
of the assays while being clearly negative (ES ELISA) or in
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Since a recombinant antigen was used in the Luminex®
assay a higher specificity can be expected than using a
complex ES antigen. At the same time, this might result in
decreased sensitivity since not all animals might develop
antibodies against Cathepsin L1. However, more samples
were detected positive with the Luminex® assay (67 vs 21),
so sensitivity should not be of great concern here. Another
explanation for the data obtained might be false positive
samples in the ES ELISA, for example due to infection
with closely related pathogens.
Conclusion
A multiplex fluorescence serum immunoassay was
successfully developed for the simultaneous detection of
antibodies produced against C. oncophora, D. viviparus
and F. hepatica in serum samples from cattle. It is char-
acterised by low cost and time, high reproducibility and
more importantly, by high sensitivity and specificity due
to the use of recombinant antigens. This platform pro-
vides rapid, high-throughput diagnostic results, allowing
the incorporation of further analytes and parameters in
the future, such as hormones, inflammatory biomarkers
and additional parasites. In particular, inclusion of O.
ostertagi should be a major aim for the future, though
recombinant antigens suitable for diagnosis are currently
not available.
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